Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P1210: Risk of post-acute sequalae of COVID-19 in patients with immune-mediated inflammatory diseasesECCO'25
Year: 2025
Authors: Vitus, E.S.(1)*;Sørensen, C.N.(1);Sandri , A.K.(1);Elmahdi, R.(1);Jess, T.(1,2);
(1)Aalborg University, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease- Department of Clinical Medicine, Copenhagen, Denmark;(2)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;
  1. 1.                   Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Mar;21(3):133–46. 2.                   Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Mar 22;27(4):601. 3.                   Ceglarek L, Boyman O. Immune dysregulation in long COVID. Nat Immunol. 2024 Apr;25(4):587–9. 
P1211: Factors Associated with the Optimization of Biological Therapy in Crohn's Disease and Ulcerative Colitis: Insights from the National GEDIIB Patient Registry in BrazilECCO'25
Year: 2025
Authors: Froes, R.(1)*;Yukie Sassaki, L.(2);Ribas Andrade , A.(3); Gouvea Faria, M.A.(4);Luz Parente, J.M.(5);Pandolfo Zabot , G.(6);Almeida, N.(7);Coelho Demetrio, W.(8);Marques dos Santos, C.H.(9); Loureiro Salgado, V.C.(10);Siffert Pereira de Souza, H.(11);Guilherme Cancela Penna , F.(12);Serafim Parra , R.(13); Menegassi, V.(14);Maximiano, F.L.(15);Oliveira Santana, G.(16); Bafutto , M.(17); Luporini, R.L.(18);Machado de Souza MACHADO DE SOUZA , M.(19);Zaltman , C.(20);Tavares da Rocha Loures, M.(21);Botelho Quaresma, A.(22);Marques Andrade, G.(23);Lima Junior , S.(24); Ferreira de Almeida e Borges, V.(25); Vieira, M.C.(26);Sari Cassol, O.(27);Miszputen, S.(28);Prudente de Andrade, L.(29); Jacarandá de Faria, R.(30);Flores, C.(31);
(1)Gastromed, Departament of Gastroenterology and Endoscopy, Rio de Janeiro, Brazil;(2)São Paulo State University Unesp, Gastroenterology, Botucatu, Brazil;(3)Hospital São Rafael, Gastroenterology, Salvador, Brazil;(4)Kaiser, Gastroenterology and Coloproctology, São José do Rio Preto, Brazil;(5)Universidade Federal do Piauí, Gastroenterology, Teresina, Brazil;(6)Coloprocto Clínica do Aparelho Digestivo, Coloproctology, Canoas, Brazil;(7)Hospital Geral Roberto Santos, Gastroenterology, Salvador, Brazil;(8)Hospital Governador Celso Ramos, Gastroenterology, Florianópolis, Brazil;(9)Fundação Universidade Federal do Mato Grosso do Sul, Coloproctology, Campo Grande, Brazil;(10)Hospital Servidores do Estado do Rio De Janeiro, Gastroenyerology, Rio de Janeiro, Brazil;(11)Universidade Federal do Rio de Janeiro, Gastroenterology, Rio de Janeiro, Brazil;(12)Instituto de Previdência do Estado de Minas Gerais, Gastroenterology, Belo Horizonte, Brazil;(13)Ribeirão Preto Medical School- University of São Paulo, Department of Surgery and Anatomy, Ribeirão Preto, Brazil;(14)Hospital Universitário Polydoro Ernani de São Thiago, Gastroenterology, Florianópolis, Brazil;(15)Faculdade de Medicina do ABC, Gastroenterology, Santo André, Brazil;(16)CLIAGEN, Gastroenterology, Salvador, Brazil;(17)Instituto Goiano de Gastroenterologia, Gastroenterology, Goiania, Brazil;(18)Speaker Janssen- Takeda e Abbvie, Coloproctology, São Carlos, Brazil;(19)Hospital Universitário Júlio Muller, Coloproctology, Cuiabá, Brazil;(20)Hospital Universitario Clementino Fraga Filho, Gastroenterology, Rio de Janeiro, Brazil;(21)Hospital Nossa Senhora das Graças, Gastroenterology, Curitiba, Brazil;(22)Universidade do Oeste Catarinense - UNOESC, Coloproctology, Joaçaba, Brazil;(23)Hospital das Clínicas - Universidade Federal de Uberlândia HC-UFU, Gastroenterology, Uberlândia, Brazil;(24)Hospital Universitário João de Barros Barreto, Coloproctology, Belém, Brazil;(25)Universidade Federal de Uberlândia, Gastroenterology, Uberlândia, Brazil;(26)Centro de Gastroenterologia Pediátrica- Hospital Pequeno Príncipe, Gastroenterology, Curitiba, Brazil;(27)Hospital de Clinicas de Passo Fundo, Coloproctology, Passo Fundo, Brazil;(28)Universidade Federal de São Paulo - UNIFESP, Gastroenterology, São Paulo, Brazil;(29)Hospital de Clínicas Samuel Libânio, Coloproctology, Pouso Alegre, Brazil;(30)Hospital Universitário de Brasília, Gastroenterology, Brasília, Brazil;(31)Centro de Referência em Crohn e Colite do Rio Grande do Sul, Gastroenterology, Porto Alegre, Brazil; On Behalf of GEDIIB

Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1655-1668.e3. doi: 10.1016/j.cgh.2019.03.037. 
Fróes RSB, Andrade AR, Faria MAG, de Souza HSP, Parra RS, Zaltman C, Dos Santos CHM, Bafutto M, Quaresma AB, Santana GO, Luporini RL, de Lima Junior SF, Miszputen SJ, de Souza MM, Herrerias GSP, Junior RLK, do Nascimento CR, Féres O, de Barros JR, Sassaki LY, Saad-Hossne R. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB. Sci Rep. 2024 Feb 21;14(1):4314. doi: 10.1038/s41598-024-54332-1. 

P1212: Effectiveness of Vedolizumab to Reduce Bowel Urgency in a Canadian Real-World Ulcerative Colitis CohortECCO'25
Year: 2025
Authors: Battat , R.(1)*;Leung , Y.(2);Tandon , P.(3);Ward , R.(4);Wadhwa , A.(4);Power , S.(4);Weiss , J.(5);Moulson , R.(5);Pettengell , C.(5);Feagan , B.G.(6);
(1)Centre hospitalier de l'Université de Montréal, Gastroenterology, Montreal, Canada;(2)University of British Columbia, Gastroenterology, Vancouver, Canada;(3)University Health Network and Mount Sinai Hospital, Gastroenterology, Toronto, Canada;(4)Takeda Canada, Gastroenterology, Toronto, Canada;(5)Pentavere Research Group, Clinical, Toronto, Canada;(6)Schulich School of Medicine & Dentistry- University of Western Ontario, Gastroenterology, London, Canada;
P1213: The role of stress in dietary choices and disease outcomes in Inflammatory Bowel DiseaseECCO'25
Year: 2025
Authors: Acampora , M.(1)*;Usta , D.(2); Costa Pereira , A.(2);Savarese , M.(3);Avedano , L.(4);De Rocchis , M.S.(4);Leone , S.(5);Graffigna , G.(6);
(1)EngageMinds HUB-Consumer- Food & Health Engagement Research Center- Università Cattolica del Sacro Cuore, Psychology, Milan, Italy;(2)EngageMinds HUB—Consumer- Food & Health Engagement Research Center- Università Cattolica del Sacro Cuore, Psychology, Cremona, Italy;(3)EngageMinds HUB—Consumer- Food & Health Engagement Research Center- Università Cattolica del Sacro Cuore, Psychology, Milan, Italy;(4)European Federation of Crohn's & Ulcerative Colitis Associations EFCCA, European Federation of Crohn's & Ulcerative Colitis Associations EFCCA, Brussels, Belgium;(5)Associazione Nazionale per le Malattie infiammatorie Croniche dell’Intestino AMICI ITALIA, Associazione Nazionale per le Malattie infiammatorie Croniche dell’Intestino AMICI ITALIA, Italy, Italy;(6)EngageMinds HUB—Consumer- Food & Health Engagement Research Center- Università Cattolica del Sacro Cuore, Faculty of Agriculture- Food and Environmental Sciences, Cremona, Italy;
P1214: Too Many Couch Potatoes Among Middle-Aged Inflammatory Bowel Disease Patients! Findings From the "BE-FIT-IBD-2" Study on Patient-Reported Physical Activity Levels Examining Their Interactions with IBD-Related Factors and Barriers/FacilitatorsECCO'25
Year: 2025
Authors: Gravina, A.G.(1)*;Pellegrino, R.(1);Palladino, G.(1);Tambaro, A.(1);De Costanzo, I.(1);Izzo, M.(1);Landa, F.(1);Federico, A.(1);
(1)University of Campania Luigi Vanvitelli, Department of Precision Medicine, Naples, Italy;

Gravina AG, Pellegrino R, Durante T, et al. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study. World J Gastroenterol. 2023;29(41):5668-5682. doi:10.3748/wjg.v29.i41.56682.
Gravina AG, Pellegrino R, Palladino G, et al. Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the "BE-FIT-IBD" study. Gastroenterol Hepatol. Published online May 8, 2024:S0210-5705(24)00161-4. doi:10.1016/j.gastrohep.2024.5022033. 
Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395. doi:10.1249/01.MSS.0000078924.61453.FB

P1215: Hospital utilisation for ulcerative colitis in Australia, 1993–2022: a review of observational separation dataECCO'25
Year: 2025
Authors: Meehan, E.(1)*;Pillay, L.(2);
(1)Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia;(2)Royal Melbourne Hospital, Gastroenterology, Melbourne, Australia;

1. Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023; 13(3), p. e065186. https://doi.org/10.1136/bmjopen-2022-065186
2. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007; 5: 103-110.
3. Seah D, De Cruz P. Review article: the practical management of acute severe ulcerative colitis. Aliment PharmacolTher. 2016; 43: 482-513.
4. Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN. Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis. Clin Gastroenterol Hepatol. 2020; 18(4):889-897. https://doi.org/10.1016/j.cgh.2019.07.022

P1216: Mapping the Ulcerative Colitis patient journey in Saudi Arabia from healthcare professionals' perspective: A cross-sectional non-interventional studyECCO'25
Year: 2025
Authors: Azzam, N.(1)*;Mosli, M.(2);Almutairdi, A.(3);Alghamdi, M.(4);Meeralam, Y.(5);Alolimi, K.(6);Arsalan, M.(6);Al-Bawardy, B.(3);
(1)King Saud University, Division of Gastroenterology- Department of Medicine, Riyadh, Saudi Arabia;(2)King Abdul-Aziz University, Division of Gastroenterology- Department of Medicine, Jeddah, Saudi Arabia;(3)King Faisal Specialist Hospital and Research Center, Division of Gastroenterology- Department of Medicine, Riyadh, Saudi Arabia;(4)AlHada Armed Force Hospital, Internal Medicine Department, Taif, Saudi Arabia;(5)King Abdullah Medical City, Gastroenterology Division, Mecca, Saudi Arabia;(6)Pfizer, Medical Affairs, Riyadh, Saudi Arabia;

Mosli M, Almudaiheem H, Alameel T, et al. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease. Saudi Journal of Gastroenterology. 2023;29(7):1-35. doi:10.4103/sjg.sjg_277_22

P1217: Epidemiology and Temporal Trends of IBD in Central TaiwanECCO'25
Year: 2025
Authors: Chen, Y.Y.(1)*;Huang, C.W.(1);Chou, J.W.(2);Yen, H.H.(1);
(1)Changhua Christian Hospital, Division of Gastroenterology, Changhua, Taiwan;(2)China Medical University Hospital, Division of Gastroenterology, Taichung, Taiwan;

1.Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. Dec 2017;44(4):673-692. doi:10.1016/j.pop.2017.07.010
2.The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. Jan 2020;5(1):17-30. doi:10.1016/s2468-1253(19)30333-4
3.Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. Mar 28 2023;13(3):e065186. doi:10.1136/bmjopen-2022-065186
4.Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. Dec 23 2017;390(10114):2769-2778. doi:10.1016/s0140-6736(17)32448-0

P1218: Pancreatic Involvement in Patients with Inflammatory Bowel Disease: A Cohort Study of 474 IBD PatientsECCO'25
Year: 2025
Authors: Darkaoui, D.(1)*;Koulali, H.(2);Zazour, A.(2);Ouiam, E.(2);Ismaili, Z.(2);Kharrasse, G.(2);
(1)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI Oujda, Oujda, Morocco;(2)Service d’Hépato-gastro-entérologie CHU MOHAMMED VI Oujda- Université Mohammed Premier Oujda- Laboratoire de recherche de maladie de l’appareil digestif LARMAD.MAROC, CHU mohamed VI, Oujda, Morocco;
P1219: Late onset inflammatory bowel disease (IBD): Experience from two tertiary centers in GreeceECCO'25
Year: 2025
Authors: Ioannou, A.(1)*;Theocharis, G.(2);Geramoutsos, G.(2);Sotiropoulos, C.(2);Koumentakis, C.(1);Leonidakis, G.(1);Pardalis, P.(1);Pantelakis, E.(1);Thomopoulos, K.(2);Michopoulos , S.(1);Zampeli, E.(1);
(1)Alexandra General Hospital, Department of Gastroenterology, Athens, Greece;(2)University Hospital of Patra, Gastroenterology Department, Patra, Greece;
  1. 1.    Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):51-65. doi: 10.4292/wjgpt.v7.i1.51. PMID: 26855812; PMCID: PMC4734955.
P1220: Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions with Genetic SusceptibilityECCO'25
Year: 2025
Authors: He, Z.(1);Sun, Y.(2);Huang, H.(3);Fu, T.(4);Yuan, S.(5);Larsson, S.C.(5);Ludvigsson, J.F.(6);Wang, X.(3);Magro, F.(7);Bai, Y.(1);Chen, J.(3)*;
(1)Changhai Hospital- Naval Medical University, Department of Gastroenterology, Shanghai, China;(2)The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China;(3)The Third Xiangya Hospital- Central South University, Department of Gastroenterology, Changsha, China;(4)Affiliated Hangzhou First People's Hospital- Westlake University Medical College, Department of Gastroenterology, Hangzhou, China;(5)Institute of Environmental Medicine- Karolinska Institutet, Unit of Cardiovascular and Nutritional Epidemiology, Stockholm, Sweden;(6)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden;(7)University of Porto, CINTESIS@RISE- Departmento- Faculty of Medicine, Porto, Portugal;
P1221: Microscopic colitis and risk of venous thromboembolism: A nationwide matched cohort studyECCO'25
Year: 2025
Authors: ForssMD PhD, A.(1,2,3)*;Bröms, G.(3,4);Bergman, D.(2);Thuresson, M.(5);Sun, J.(2);Eriksson, C.(3,6);Olén, O.(3,7);Zöller, B.(8);Ludvigsson, J.F.(2,9,10);
(1)Karolinska University Hospital, Centre for Digestive Health- Department of Gastroenterology- Dermatovenereology and Rheumatology, Solna, Sweden;(2)Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden;(3)Karolinska Institutet, Clinical Epidemiology Division- Department of Medicine Solna, Stockholm, Sweden;(4)Danderyd Hospital, Division of Gastroenterology- Department of Specialist Medicine, Stockholm, Sweden;(5)Statisticon AB, Statisticon AB, Uppsala, Sweden;(6)Örebro University, Department of Gastroenterology- Faculty of Medicine and Health, Örebro, Sweden;(7)Stockholm South General Hospital, Sachs’ Children and Youth Hospital, Stockholm, Sweden;(8)Lund University/Region Skåne, Center for Primary Health Care Research- Department of Clinical Sciences, Lund, Sweden;(9)Columbia University College of Physicians and Surgeons, Department of Medicine, New York, United States;(10)Örebro University Hospital, Department of Paediatrics, Örebro, Sweden;
P1222: The macroscopic and microscopic distribution of IBD in patients with PSC: a polytomous latent class analysis on 3177 endoscopiesECCO'25
Year: 2025
Authors: Sneek, D.(1)*;van der Meer, A.(1);Mol, B.(2);Ponsioen, C.(2);Inderson, A.(3);Weersma, R.(4);Hansen, B.(5);de Vries, A.(1);
(1)Erasmus MC University Medical Center, Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Amsterdam University Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(3)Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands;(4)University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands;(5)Erasmus MC University Medical Center, Biostatistics, Rotterdam, The Netherlands; EpiPSC2

1. van Munster KN, Bergquist A, Ponsioen CY. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two? J Hepatol. 2024;80(1):155-68.2.
2. Lewis J, Linzer D. poLCA: An R Package for Polytomous Variable Latent Class Analysis. Journal of Statistical Software. 2011;42

P1223: Maternal dietary patterns during pregnancy and offspring’s risk of paediatric Inflammatory Bowel Disease - a cohort studyECCO'25
Year: 2025
Authors: AnnebergMSc, O.M.R.(1)*;Halldórsson, Þ.I.(2,3);Olsen, S.F.(2,4,5);Bjerregaard, A.A.(2,6);Hansen, A.V.(1);Jess, T.(1,7);De Freitas, M.B.(1);
(1)Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;(2)Statens Serum Institute, Department of Epidemiology Research, Copenhagen, Denmark;(3)University of Iceland, Faculty of Food Science and Nutrition, Reykjavik, Iceland;(4)Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, United States;(5)University of Copenhagen, Department of Public Health, Copenhagen, Denmark;(6)Copenhagen University Hospitals – Bispebjerg and Frederiksberg, Centre for Clinical Research and Prevention, Copenhagen, Denmark;(7)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;
P1224: Bidirectional association between sleep pattern and inflammatory bowel disease: a large population-based prospective cohort studyECCO'25
Year: 2025
Authors: Le, K.(1);Liu, Y.(1);Bai, R.(2);Sheng, J.(2);Zhu, J.(1);Xie, S.(1);Ma, D.(1);Liu, Z.(1)*;
(1)Zhejiang University, Children's Hospital, Hangzhou, China;(2)Zhejiang University, Sir Run Run Shaw Hospital, Hangzhou, China;

Sleep disorders and inflammatory disease activity: chicken or the egg? Am J Gastroenterol. 2015 Apr;110(4):484-8.

P1225: A cross-sectional study of Inflammatory Bowel Disease in older people across Australasia, a Crohn’s Colitis Cure data insights programECCO'25
Year: 2025
Authors: Seng, C.(1)*;Su, W.K.(2,3,4);Wilson, W.(5);Connor, S.J.(2,3,6);Andrews, J.M.(2,7,8);Walker, G.(1,9,10);
(1)The Royal Brisbane and Women's Hospital, Gastroenterology, Brisbane, Australia;(2)Crohn's Colitis Cure, Sydney, New South Wales, Australia;(3)The Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(4)Liverpool Hospital, Department of Gastroenterology and Hepatology, Sydney, Australia;(5)Lyell McEwin Hospital, Adelaide, South Australia, Australia;(6)University of New South Wales, South West Sydney Clinical Campuses, Sydney, Australia;(7)University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(8)Central Adelaide Local Health Network, Adelaide, South Australia, Australia;(9)QIMR Berghofer, Brisbane, Queensland, Australia;(10)University of Queensland, Brisbane, Queensland, Australia;
P1226: Inflammatory Bowel Diseases and Prior Malignant Diagnoses - A Danish Nationwide Cohort Study 1996-2022ECCO'25
Year: 2025
Authors: Plovgaard, J.(1)*;Damsgaard Wewer, M.(1,2);Bendtsen, F.(1,2,3);Burisch, J.(1,2,3);
(1)Hvidovre Hospital- University of Copenhagen, Gastro Unit- Medical Division, Hvidovre, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(3)University of Copenhagen, Department of Clinical Medicine- Faculty of Health and Medical Sciences, Copenhagen, Denmark;
P1227: Predictors of biologics/JAKi use, surgeries, and hospitalisations in a newly diagnosed cohort of IBD patients: Long-term outcomes from the nationwide EpidemIBD study of GETECCUECCO'25
Year: 2025
Authors: Garre, A.(1)*;Núñez Ortiz, A.(2);Rubio, S.(3);Diz-Lois Palomares, M.T.(4);Riestra, S.(5);Alonso-Galán, H.(6);Fernández-Salgado, E.(7);Ferreiro-Iglesias, R.(8);Vela, M.(9);Ponferrada Díaz, Á.(10);Sánchez Rodríguez, E.(11);Hernández, V.(12);Arias García, L.(13);Barrio, J.(14);Huguet, J.M.(15);Ginard, D.(16);Rivero, M.(17);Vera, I.(18);Alonso-Abreu, I.(19);Benítez, J.M.(20);Aguas, M.(21);Rodríguez-Lago, I.(22);Calvet, X.(23);Fernández-Salazar, L.(24);Echarri, A.(25);Arroyo, M.T.(26);Navarro-Llavat, M.(27);Vega, P.(28);Sierra, M.(29);Guerra del Río, E.(30);Vicente, R.(31);Casanova, M.J.(1);Navarro, P.(32);Ortiz de Zarate, J.(33);Varela Trastoy, P.(34);Spicakova, K.(35);Gutiérrez, A.(36);Martín-Arranz, M.D.(37);P. Gisbert*, J.(1);Chaparro*, M.(1);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid UAM- and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Department of Gastroenterology, Madrid, Spain;(2)Hospital Universitario Virgen del Rocío, Department of Gastroenterology, Sevilla, Spain;(3)Hospital Universitario de Navarra, Department of Gastroenterology, Pamplona, Spain;(4)Hospital Universitario A Coruña, Department of Gastroenterology, A Coruña, Spain;(5)Hospital Universitario Central de Asturias and ISPA, Department of Gastroenterology, Asturias, Spain;(6)Hospital Universitario Donostia and Instituto Biogipuzkoa, Department of Gastroenterology, San Sebastián, Spain;(7)Complexo Hospitalario Universitario de Pontevedra- Instituto de Investigación Sanitaria Galicia Sur, Department of Gastroenterology, Pontevedra, Spain;(8)Complexo Hospitalario Universitario de Santiago and Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Department of Gastroenterology, Santiago de Compostela, Spain;(9)Complejo Hospitalario Universitario Ntra. Sra. de Candelaria, Department of Gastroenterology, Santa Cruz de Tenerife, Spain;(10)Hospital Universitario Infanta Leonor, Department of Gastroenterology, Madrid, Spain;(11)Hospital Ramón y Cajal, Department of Gastroenterology, Madrid, Spain;(12)Hospital Álvaro Cunqueiro- Estrutura Organizativa de Xestión Integrada de Vigo, Department of Gastroenterology, Vigo, Spain;(13)Hospital Universitario de Burgos, Department of Gastroenterology, Burgos, Spain;(14)Hospital Universitario Rio Hortega, Department of Gastroenterology, Valladolid, Spain;(15)Consorcio Hospital General Universitario de Valencia, Department of Gastroenterology, Valencia, Spain;(16)Hospital Universitari Son Espases, Department of Gastroenterology, Palma de Mallorca, Spain;(17)Hospital Universitario Marqués de Valdecilla and IDIVAL, Department of Gastroenterology, Santander, Spain;(18)Hospital Universitario Puerta de Hierro Majadahonda, Department of Gastroenterology, Madrid, Spain;(19)Hospital Universitario de Canarias H.U.C., Department of Gastroenterology, Santa Cruz de Tenerife, Spain;(20)Hospital Universitario Reina Sofía and IMIBIC, Department of Gastroenterology, Córdoba, Spain;(21)Hospital Universitari i Politecnic La Fe, Department of Gastroenterology, Valencia, Spain;(22)Hospital de Galdakao-Usansolo, Department of Gastroenterology, Galdakao. Vizcaya, Spain;(23)Hospital de Sabadell- Institut Universitari Parc Taulí- Universitat Autònoma de Barcelona- CIBEREHD, Department of Gastroenterology, Sabadell. Barcelona, Spain;(24)Hospital Clínico Universitario de Valladolid, Department of Gastroenterology, Valladolid, Spain;(25)Complejo Hospitalario Universitario de Ferrol, Department of Gastroenterology, A Coruña, Spain;(26)Hospital Clínico Universitario “Lozano Blesa”- IIS Aragón and CIBERehd, Department of Gastroenterology, Zaragoza, Spain;(27)Hospital de Sant Joan Despí Moisès Broggi, Department of Gastroenterology, Barcelona, Spain;(28)Complexo Hospitalario Universitario de Ourense, Department of Gastroenterology, Ourense, Spain;(29)Complejo Asistencial Universitario de León, Department of Gastroenterology, León, Spain;(30)Hospital Universitario de Gran Canaria Dr. Negrín, Department of Gastroenterology, Las Palmas, Spain;(31)Hospital Universitario Miguel Servet, Department of Gastroenterology, Zaragoza, Spain;(32)Hospital Clínico Universitario de Valencia- Universitat de València, Department of Gastroenterology, Valencia, Spain;(33)Hospital Universitario de Basurto, Department of Gastroenterology, Bilbao, Spain;(34)Hospital de Cabueñes, Department of Gastroenterology, Gijón, Spain;(35)Hospital Universitario de Araba sede Txagorritxu y sede Santiago, Department of Gastroenterology, Álava, Spain;(36)Hospital General Universitario Dr. Balmis and CIBERehd, Department of Gastroenterology, Alicante, Spain;(37)Hospital Universitario de La Paz. Universidad Autónoma de Madrid. Instituto de Investigación Hospital Universitario de La Paz, Department of Gastroenterology, Madrid, Spain; on behalf of the EpidemIBD study group of GETECCU. *Both authors share senior authorship
P1228: Cancer incidence in patients with inflammatory bowel disease: A nationwide population-based study from KoreaECCO'25
Year: 2025
Authors: Seo, J.(1)*;Lee, J.W.(2);Kim, K.(1);Lim, H.(1);Jung, S.Y.(2);Choi, C.H.(1);
(1)Chung-Ang University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(2)Chung-Ang University, College of Pharmacy, Seoul, Korea- Republic Of;

1.Gordon H, Biancone L, Fiorino G, et al. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. J Crohns Colitis. 2023;17(6):827-854. doi:10.1093/ecco-jcc/jjac187
2.Scharl S, Barthel C, Rossel JB, et al. Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study. Am J Gastroenterol. 2019;114(1):116-126. doi:10.1038/s41395-018-0360-9
3.Jung YS, Han M, Park S, Kim WH, Cheon JH. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study. J Crohns Colitis. 2017;11(8):954-962. doi:10.1093/ecco-jcc/jjx040
4.Kim HM, Kim JH, Lee JK, et al. Age- and sex-specific risk of colorectal cancer in incident ulcerative colitis during the first 10 years after diagnosis: a nationwide population-based study. Scand J Gastroenterol. 2021;56(11):1279-1285. doi:10.1080/00365521.2021.1958370

P1229: Updated Epidemiology of Osteoporosis in the Inflammatory Bowel Disease Population and Associated Risk Factors: Insights from a Retrospective Cohort AnalysisECCO'25
Year: 2025
Authors: Khataniar, H.(1);Desai, A.(2);Kochhar, G.(3)*;
(1)Allegheny General Hospital, Department of Medicine- Allegheny Health Network- Pittsburgh- PA, Pittsburgh, United States;(2)Allegheny Health Network, Division of Gastroenterology- Hepatology and Nutrition- Allegheny Health Network- Pittsburgh- PA, Pittsburgh, United States;(3)Allegheny Health Network, Division of Gastroenterology- Hepatology and Nutrition- Allegheny Health Network- Pittsburgh- PA, Wexford, United States;

1. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul;122(7):599-604. doi: 10.1016/j.amjmed.2009.01.022. PMID: 19559158; PMCID: PMC2894700.